[HTML][HTML] Staphylococcus aureus host interactions and adaptation

BP Howden, SG Giulieri, T Wong Fok Lung… - Nature Reviews …, 2023 - nature.com
Invasive Staphylococcus aureus infections are common, causing high mortality,
compounded by the propensity of the bacterium to develop drug resistance. S. aureus is an …

[HTML][HTML] Overcoming Cancer Multi-drug Resistance (MDR): Reasons, mechanisms, nanotherapeutic solutions, and challenges

C Duan, M Yu, J Xu, BY Li, Y Zhao… - Biomedicine & …, 2023 - Elsevier
Multi-drug resistance (MDR) in cancer cells, either intrinsic or acquired through various
mechanisms, significantly hinders the therapeutic efficacy of drugs. Typically, the reduced …

[HTML][HTML] Insights for precision oncology from the integration of genomic and clinical data of 13,880 tumors from the 100,000 Genomes Cancer Programme

A Sosinsky, J Ambrose, W Cross, C Turnbull… - Nature Medicine, 2024 - nature.com
Abstract The Cancer Programme of the 100,000 Genomes Project was an initiative to
provide whole-genome sequencing (WGS) for patients with cancer, evaluating opportunities …

[HTML][HTML] Big data in basic and translational cancer research

P Jiang, S Sinha, K Aldape, S Hannenhalli… - Nature Reviews …, 2022 - nature.com
Historically, the primary focus of cancer research has been molecular and clinical studies of
a few essential pathways and genes. Recent years have seen the rapid accumulation of …

[HTML][HTML] Access and quality of biomarker testing for precision oncology in Europe

N Normanno, K Apostolidis, A Wolf, R Al Dieri… - European journal of …, 2022 - Elsevier
Background Predictive biomarkers are essential for selecting the best therapeutic strategy in
patients with cancer. The International Quality Network for Pathology, the European Cancer …

Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer

Y Pradat, J Viot, AA Yurchenko, K Gunbin, L Cerbone… - Cancer discovery, 2023 - AACR
Metastatic relapse after treatment is the leading cause of cancer mortality, and known
resistance mechanisms are missing for most treatments administered to patients. To bridge …

[HTML][HTML] Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: opportunities for integration and pitfalls to interpretation

EM Kwan, AW Wyatt, KN Chi - Frontiers in Oncology, 2022 - frontiersin.org
Plasma circulating tumor DNA (ctDNA) represents short fragments of tumor-derived DNA
released into the bloodstream primarily from cancer cells undergoing apoptosis. In …

Nanozyme-enhanced ferroptosis for cancer treatment

Y Ming, M Huang, Y Huang, D Liu, M Sun… - Materials Chemistry …, 2024 - pubs.rsc.org
Ferroptosis is a programmed, iron-dependent, oxidative cell death that was discovered
recently. It is usually accompanied by iron accumulation and lipid peroxidation during the …

[HTML][HTML] New clinical trial design in precision medicine: discovery, development and direction

XP Duan, BD Qin, XD Jiao, K Liu, Z Wang… - Signal Transduction and …, 2024 - nature.com
In the era of precision medicine, it has been increasingly recognized that individuals with a
certain disease are complex and different from each other. Due to the underestimation of the …

[HTML][HTML] Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration

ES Tsang, V Csizmok, LM Williamson… - NPJ Precision …, 2023 - nature.com
There is emerging evidence about the predictive role of homologous recombination
deficiency (HRD), but this is less defined in gastrointestinal (GI) and thoracic malignancies …